Variant report
Variant | esv3383105 |
---|---|
Chromosome Location | chr20:11467104-11468864 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs146802182 | chr20:11467129-11467130 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs569420810 | chr20:11467172-11467173 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs117856599 | chr20:11467183-11467184 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs148930299 | chr20:11467250-11467251 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs143635234 | chr20:11467297-11467298 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs371352122 | chr20:11467317-11467318 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs189307959 | chr20:11467325-11467326 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs554187611 | chr20:11467341-11467342 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs573568520 | chr20:11467350-11467351 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs542288484 | chr20:11467388-11467389 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs113148228 | chr20:11467396-11467397 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs6134260 | chr20:11467417-11467418 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs534389200 | chr20:11467442-11467443 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs6134261 | chr20:11467448-11467449 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs555840001 | chr20:11467469-11467470 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs62191909 | chr20:11467471-11467472 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs564296801 | chr20:11467472-11467473 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs6134262 | chr20:11467478-11467479 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs533194013 | chr20:11467480-11467481 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs6134263 | chr20:11467487-11467488 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs6104758 | chr20:11467523-11467524 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs527510165 | chr20:11467562-11467563 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs370040905 | chr20:11467576-11467577 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs561053109 | chr20:11467605-11467606 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs529283217 | chr20:11467611-11467612 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs192657038 | chr20:11467660-11467661 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs184183160 | chr20:11467661-11467662 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs4142357 | chr20:11467663-11467664 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs551923511 | chr20:11467664-11467665 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs190329239 | chr20:11467686-11467687 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs6040732 | chr20:11467696-11467697 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
32 | rs181154959 | chr20:11467720-11467721 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs567912989 | chr20:11467725-11467726 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs539902762 | chr20:11467743-11467744 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs201387594 | chr20:11467798-11467799 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs549096758 | chr20:11467809-11467810 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs35962772 | chr20:11467810-11467811 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs536236674 | chr20:11467819-11467820 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs559956027 | chr20:11467822-11467823 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs555701075 | chr20:11467905-11467906 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs117438970 | chr20:11468024-11468025 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs544676091 | chr20:11468026-11468027 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs558264830 | chr20:11468095-11468096 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs532172765 | chr20:11468099-11468100 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs369713258 | chr20:11468122-11468123 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs572184300 | chr20:11468123-11468124 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs377561164 | chr20:11468205-11468206 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs540913540 | chr20:11468206-11468207 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs151120942 | chr20:11468213-11468214 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs80164350 | chr20:11468226-11468227 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 16397240 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Wilms tumour | 21544195 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 16272173 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 19627613 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Gastric cancer | 17908304 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Colorectal cancer | 21645411 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Autism | 22495311 | CNVD |
Glaucoma | 21310917 | CNVD |
Alagille syndrome | 22470819 | CNVD |
Lung cancer | 16773561 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Alagille syndrome | 17576883 | CNVD |
Anaplastic large cell lymphoma | 18179710 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21804112 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ewing''s sarcoma | 18628472 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Breast cancer | 20409316 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr20:11466400-11467600 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
2 | chr20:11467600-11469000 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
3 | chr20:11468000-11469000 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |